威尔药业：2025年半年度净利润约7277万元

Core Viewpoint - Weir Pharmaceuticals reported a decline in both revenue and net profit for the first half of 2025 compared to the same period in the previous year [2] Financial Performance - The company's revenue for the first half of 2025 was approximately 674 million yuan, representing a year-on-year decrease of 2.1% [2] - The net profit attributable to shareholders was around 72.77 million yuan, which is a year-on-year decrease of 7.77% [2] - Basic earnings per share were 0.54 yuan, reflecting a year-on-year decrease of 6.9% [2]